149 related articles for article (PubMed ID: 3667370)
21. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
[TBL] [Abstract][Full Text] [Related]
22. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?
Fukunaga-Johnson N; Lee JH; Sandler HM; Robertson P; McNeil E; Goldwein JW
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):143-6. PubMed ID: 9747831
[TBL] [Abstract][Full Text] [Related]
23. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
[TBL] [Abstract][Full Text] [Related]
24. Treatment of medulloblastoma with procarbazine, hydroxyurea, and reduced radiation doses to whole brain and spine.
Levin VA; Rodriguez LA; Edwards MS; Wara W; Liu HC; Fulton D; Davis RL; Wilson CB; Silver P
J Neurosurg; 1988 Mar; 68(3):383-7. PubMed ID: 3343610
[TBL] [Abstract][Full Text] [Related]
25. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
[TBL] [Abstract][Full Text] [Related]
26. Medulloblastoma in adults: treatment results and prognostic factors.
Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
[TBL] [Abstract][Full Text] [Related]
27. Pediatric medulloblastoma: radiation treatment technique and patterns of failure.
Miralbell R; Bleher A; Huguenin P; Ries G; Kann R; Mirimanoff RO; Notter M; Nouet P; Bieri S; Thum P; Toussi H
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):523-9. PubMed ID: 9112448
[TBL] [Abstract][Full Text] [Related]
28. Myelography in the assessment of children with medulloblastoma.
O'Reilly G; Hayward RD; Harkness WF
Br J Neurosurg; 1993; 7(2):183-8. PubMed ID: 8494621
[TBL] [Abstract][Full Text] [Related]
29. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
[TBL] [Abstract][Full Text] [Related]
30. Improving the therapeutic ratio of craniospinal irradiation in medulloblastoma.
Maor MH; Fields RS; Hogstrom KR; van Eys J
Int J Radiat Oncol Biol Phys; 1985 Apr; 11(4):687-97. PubMed ID: 3980265
[TBL] [Abstract][Full Text] [Related]
31. Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.
Acharya S; Guo Y; Patni T; Li Y; Wang C; Gargone M; Ashford JM; Wilson L; Faught A; Reddick WE; Patay Z; Gajjar A; Conklin HM; Merchant TE
J Clin Oncol; 2022 Jan; 40(1):83-95. PubMed ID: 34714708
[TBL] [Abstract][Full Text] [Related]
32. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy.
Gajjar A; Mulhern RK; Heideman RL; Sanford RA; Douglass EC; Kovnar EH; Langston JA; Jenkins JJ; Kun LE
J Clin Oncol; 1994 Jun; 12(6):1212-6. PubMed ID: 8201384
[TBL] [Abstract][Full Text] [Related]
33. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.
Merchant TE; Wang MH; Haida T; Lindsley KL; Finlay J; Dunkel IJ; Rosenblum MK; Leibel SA
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):29-35. PubMed ID: 8823256
[TBL] [Abstract][Full Text] [Related]
34. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
35. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
[TBL] [Abstract][Full Text] [Related]
36. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: early results of a pilot study.
Prados MD; Wara WM; Edwards MS; Cogen PH
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):431-8. PubMed ID: 8276658
[TBL] [Abstract][Full Text] [Related]
37. A modified radiotherapy technique in the treatment of medulloblastoma.
Dewit L; Van Dam J; Rijnders A; van de Velde G; Ang KK; van der Schueren E
Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):231-41. PubMed ID: 6423583
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
Mulhern RK; Kepner JL; Thomas PR; Armstrong FD; Friedman HS; Kun LE
J Clin Oncol; 1998 May; 16(5):1723-8. PubMed ID: 9586884
[TBL] [Abstract][Full Text] [Related]
39. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma.
Lew SM; Morgan JN; Psaty E; Lefton DR; Allen JC; Abbott R
J Neurosurg; 2006 Feb; 104(2 Suppl):103-7. PubMed ID: 16506497
[TBL] [Abstract][Full Text] [Related]
40. [Radiotherapy of cerebellar medulloblastoma in children].
Shcherbenko OI; Zelinskaia NI; Parkhomenko RA; Ardatova GV; Hechaeva VN
Vopr Onkol; 1999; 45(1):95-7. PubMed ID: 10941376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]